0.05-1 μm in diameter, which are generated by the outward budding and fission of membrane vesicles from the cell surface.
4 MV was once regarded as "cellular dust", but this view has been subjected to debates and discussions. Recent studies have found that MV, as an important carrier of biological information, can carry membrane receptor, protein, mRNA, miRNA, etc., and can be used to reprogram for target cell.
5 MV mainly bind membrane surface ligand and target cell surface receptor to form a complex signal, and then to stimulate the target cells. They can also transport protein, mRNA and biologically active lipids for target cells to affect the biological function. The function of MV depends on the cargo they carry. In turn, it is dependent on the cell type from which they originate. In the steady state, the order of abundance is plateletderived MV (80%), endothelium-derived MV (10%), and leukocyte-derived MV (10%). 6 It had been reported that pathogenic microorganisms induced the host cell to release the corresponding cell-derived MV after infection. When activated and infected, cell could secrete highly specific MV.
7 MV released by the infected cells with the characteristics 
PATIENTS AND METHODS

Patients
A total of 32 SFTS patients aged 35-55 years who were admitted to Department of Infectious Diseases of Union Hospital, Tongji Medical College, Huazhong University of Science and Technology between May 2012 and September 2012 were included in this study. All patients had a clinical diagnosis. Plasma of 7 patients in the beginning of the epidemic in May were collected and viral RNA were extracted for sequencing, and finally bunyavirus infection was confirmed. Other specimens were collected by the Center for Disease Control and Prevention of Wuhan City, and SFTS virus genes were detected by RT-PCR from the patient's blood. And control samples from 21 healthy volunteers were also collected. All patients and volunteers signed informed consents. The study was also approved by the ethics committee of the hospital.
Samples collection and preparation
After an overnight fast, 3 ml fresh peripheral blood sample was drawn from all patients and the controls in the fasting state. Blood samples were collected in EDTA containing tubes, which were immediately sent to the laboratory and prepared for the next steps. The whole blood was centrifuged at 2 000 g for 10 min to isolate blood plasma, and then centrifuged at 2 500 g for 20 min at 4℃ and the precipitate was discarded prior to further ultracentrifugation at 16 000 g for 1 hour at 4℃ with collected supernatants. The precipitation contained MV, which were resuspended in lysate and then stored at -80℃ preparing for use.
Transmission electron microscopy MV were processed by 2.5% glutaraldehyde before dehydrating, embedding, slicing and staining. Then Jeol 1210 transmission electron microscope was applied to examine the sections and take pictures.
MV detection
The concentration of MV was detected with BCA protein quantification. Firstly, working solution was prepared: the tender green standard working solution is composed of the mixture of 50 volumes of BCA alkaline solution and 1 volume of copper sulfate solution. Secondly, standard protein solution was prepared: 2 mg/ml standard bovine serum albumin was diluted with PBS to make a final concentration of 2, 1.5, 1, 0.75, 0.5, 0.25, 0.125, 0.025, 0 mg/ml. Thirdly, the mixture of 5μl sample and 100 μl working liquid was bathed in water at 37℃ for 30 min. Fourthly, the optical density (A) values at 562 nm were measured.
Statistical analysis
Data were analyzed by SPSS 17.0 statistical analysis software and were shown as means ± SD. Comparison of various groups were performed using the Student's t test. And P values ＜ 0.05 were considered statistically significant.
RESULTS
Morphology of MV under the transmission electron microscope
The morphology of acquired MV were furtherly observed by electron microscope. Under the electron microscope, the diameter of MV from SFTS patients was less than 1 μm, which were around cells in Figure  1A as well as for the normal controls in Figure 1B . Meanwhile, our results also confirmed that there was no significant difference between morphology of MV derived from the peripheral blood of SFTS patients and MV derived from normal controls (Figure 1 ).
Level of MV in circulating peripheral blood of SFTS patients
Our results showed that the level of MV in 32 SFTS patients was 4.86 ± 2.18 μg/ml, and 3.0 ± 1.28 μg/ml for the normal control, with significantly difference (P < 0.05, Figure 2) . It demonstrated the presence of high levels of MV in circulating peripheral blood of SFTS patients.
The correlationship between the severity of SFTS and the level of MV According to the condition severity of the SFTS patients, samples were divided into three groups: mild group, moderate group and severe group. The standards of mild group were leucocyte count (3-4) × 10 9 /L, platelet count (70-100) × 10 9 /L and the temperature < 38 ℃, with no significant organ dysfunction. The standards of moderate group were leucocyte count (2-3) × 10 9 /L, platelet count (30-70) × 10 9 /L, the temperature ranging from 38 ℃ to 39 ℃ and with two organs dysfunction. The standards for severe group were leucocyte count < 2 × 10 9 /L, platelet count < 30 × 10 9 /L, the temperature > 39 ℃ and multiple organ dysfunction, even systemic inflammatory response syndrome (SIRS), disseminated intravascular coagulation (DIC) tendency. The concentration of MV for mild SFTS patients was 3.42 ± 1.54 μg/ml, 5.04 ± 2.52 μg/ml for moderate SFTS patients, and 5.84 ± 2.23 μg/ml for severe SFTS patients (Figure 3) . The level of MV was closely related with the severity of SFTS, namely the higher the concentration of MV, the severer the disease was.
The correlationship between the level of MV in SFTS patients and leucocyte count If SFTS patients were in the early stages of the disease, namely in the onset of the first week, the leucocyte count was less than 4×10 9 / L, with the average expression level of MV as 3.06 ± 1.04 μg/ml. On the condition that SFTS patients with secondary infection (positive results of blood culture and sputum culture), the leucocyte count was higher than 10 × 10 9 /L, and the level of MV was 5.33 ± 2.08 μg/ml. During the recovery period, the leucocyte count gradually returned to normal, and the levels of MV was 5.54 ± 2.29 μg/ml (Figure 4) . Statistical analysis showed that leucocyte count was positively correlated (P < 0.05) with the MV level (the correlation coefficient r = 0.243). 
The correlationship between the level of MV in SFTS patients and platelet count
According to the levels of thrombocytopenia, SFTS patients were divided into three groups: mild group, moderate group and severe group. In the mild group, platelet count was higher than 70 × 10 9 /L, and the level of MV was 3.73 ± 1.83 μg/ml. In the moderate group, platelets were (30 -70) × 10 9 /L, and the MV level was 4.15 ± 1.42 μg/ml. In the severe group, platelet count was lower than 30 ×10 9 /L, and MV level was 6.48 ± 2.77 μg/ml ( Figure 5 ). Bleeding did not occur in SFTS patients. Even with equal platelet count, the MV level in SFTS patients with subcutaneous ecchymosis was lower than that in SFTS patients without ecchymosis. Meanwhile, the correlationship analysis showed that there was no significant correlationship between the MV level and platelet count, with correlation coefficient r as 0.193, P > 0.05.
DISCUSSION
SFTS is an emerging infectious disease in recent years in China. In this study, we observed the molecular characteristics of the MV in the circulating peripheral blood of SFTS patients to explore the relationship between MV and SFTS. We found that the expression level of MV in SFTS patients was obviously higher than that in the control group. The results demonstrated that there existed a higher level MV in the circulating peripheral blood of SFTS patients. It showed that the expression level of MV was correlated with the severity of SFTS. Namely, the severer the disease changed, the higher the expression level of MV was. Previous studies have shown that MV widely existed in the surrounding of the host cells as an information carrier, which greatly helped to increase the opportunity of infection with host cells. MV can transport virulence factors and other pathogenic ingredients to the host cells.
9,10 Simultaneously, the specific MV excreted by pathogens with antigen component can stimulate leucocyte, platelet, endothelial cells and fully activate inflammation, coagulation system and the immune response of complex network systems. Thereby, serious consequences include SIRS, multiple organ dysfunction syndrome (MODS), DIC and so on may occur. We speculated that MV might play a pro-thrombotic and pro-inflammatory roles through stimulating platelets, leukocytes to aggravate the conditions. On the other hand, they could also raise immune cells such as monocytes, T lymphocytes, B lymphocytes, NK cells to stimulate immune responses and cause immune pathological damages, even multiple organ dysfunction syndromes.
11 So MV may be one of the reasons which make SFTS more serious.
Our study also found that the level of MV was positively correlated with leukocyte count. Taking the occurrence mechanism of MV into account, we speculated that SFTS pathogens firstly bind to leucocytes through related receptors, such as P-selectin glycoprotein ligand-1 after infection, and then encroach upon their cytoplasm to entice TF (tissue factor, TF) expression and produce MV containing TF. After the destruction of cell structure, the SFTS pathogens released into circulating blood decreased the level of leukocytes, but enhanced the level of MV. On the condition that SFTS patients were in secondary infection, their levels of leukocytes and MV were higher than those in the normal control. The level of MV was positively correlated with leucocyte count. It indicated that SFTS patients with the secondary infection were more serious than SFTS patients without the secondary infection. Otherwise, the level of MV of SFTS patients in recovery phase was higher than that of SFTS patients in acute phase, which may be related to MV metabolic cycle. As a large number of MV derived from leukocytes of SFTS patients still remain in the initial stage, and MV continued to be produced when the leucocyte count was normal in this stage, so MV were at a high concentration compared with the initial stage. Therefore, MV derived from leucocytes in SFTS may be effective indicators to assess the severity of SFTS.
The results also showed that MV level from SFTS patients with platelet count lower than 30 ×10 9 /L was higher than that of patients with platelet count higher than 30 ×10 9 /L. MV level of SFTS patients without bleeding was distinctly higher than that of SFTS patients with bleeding. It is reported that cells released various MV in different states, different types, different stimulation conditions, and with different functions. MV content was lower than 3% when the platelets were in resting state. But once they were activated, MV increased significantly. Therefore, MV derived from platelets were the products of platelet activation, also a type of potent coagulant. As GP-Ⅰb, GP Ⅱ b -Ⅲ a, P-selectin, Ca 2 + dependent protease and pro-coagulant phospholipid(s) were rich in platelet-derived MV membranes, which could furtherly activate platelets and provide greater phospholipids catalytic surface for coagulation cascade.
12 As far as promotion of clotting effect is concerned, platelet-derived MV are 50-100 times stronger than the activated platelets.
13 Therefore, platelet-derived MV may play an important role on the coagulation in SFTS. But we have not found that the SFTS patients with the high level of MV had thrombosis. We also found that platelet number had no significant correlationship with MV level in SFTS patients.
Numerous studies have also showed that the pathogenic microorganism can make host cells release corresponding MV originated from cells after contraction of the host and it can also release the pathogen-specific MV.
9,10 These are the reasons for MV level increasing. Therefore, we speculated that increased MV level in SFTS patients might partly come from the fragments of SFTSV which were formed by the destruction and decomposition. These fragments were MV-specific components, and might play a special role in the occurrence and development of SFTS.
In conclusion, our study has explored the relationship between MV and SFTS for the first time. In SFTS patients, MV increased significantly and might play important roles in the development of SFTS. MV level was positively correlated with the severity of SFTS and the level of white blood cells. Platelet-derived MV were also important in the procession of SFTS. MV level in SFTS patients may become an indicator which can be used for diagnosis and prognosis of SFTS patients.
